UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE
Programs
Medical Research Support Initiative
THE RESEARCH INSTITUTE WAS ESTABLISHED IN 1992 TO PROMOTE, SUPPORT, AND ENHANCE MEDICAL RESEARCH FOR THE BENEFIT OF THE PUBLIC BY ADMINISTERING FUNDED RESEARCH PROJECTS ON BEHALF OF THE UNIVERSITY OF KANSAS MEDICAL CENTER (KUMC). THE RESEARCH INSTITUTE'S OBJECTIVES ARE TO: 1) SERVE KUMC BY PROMOTING AND OPERATING AT THE HIGHEST LEVEL OF ADMINISTRATIVE AND FINANCIAL HONESTY AND INTEGRITY, 2) FOSTER INDIVIDUAL A CONSORTIA PARTNERSHIPS BETWEEN KUMC RESEARCHERS AND NATIONAL, REGIONAL AND LOCAL RESEARCH BIO-MEDICAL COMMUNITIES, 3) ENHANCE REVENUE TO RESEARCHERS AND THE UNIVERSITY THROUGH THE TRANSFER OF RESEARCH DISCOVERIES AND OTHER INFORMATION TO THE PRIVATE SECTOR; AND 4) FACILITATE COOPERATIVE RESEARCH INTERACTIONS DOMESTICALLY AND INTERNATIONALLY BETWEEN THE KUMC AND CORPORATIONS, AND WITH OTHER RESEARCH CENTERS THROUGHOUT THE GREATER KANSAS CITY METROPOLITAN AREA.GeographiesNot indicatedDatesJul 1, 2022 – Jun 30, 2023Source990No causes providedNo populations provided–$161.4MProgram 1 [2024]
THE RESEARCH INSTITUTE WAS ESTABLISHED IN 1992 TO PROMOTE, SUPPORT, AND ENHANCE MEDICAL RESEARCH FOR THE BENEFIT OF THE PUBLIC BY ADMINISTERING FUNDED RESEARCH PROJECTS ON BEHALF OF THE UNIVERSITY OF KANSAS MEDICAL CENTER (KUMC). THE RESEARCH INSTITUTE'S OBJECTIVES ARE TO: 1) SERVE KUMC BY PROMOTING AND OPERATING AT THE HIGHEST LEVEL OF ADMINISTRATIVE AND FINANCIAL HONESTY AND INTEGRITY, 2) FOSTER INDIVIDUAL CONSORTIA PARTNERSHIPS BETWEEN KUMC RESEARCHERS AND NATIONAL, REGIONAL AND LOCAL RESEARCH BIO-MEDICAL COMMUNITIES, 3) ENHANCE REVENUE TO RESEARCHERS AND THE UNIVERSITY THROUGH THE TRANSFER OF RESEARCH DISCOVERIES AND OTHER INFORMATION TO THE PRIVATE SECTOR; AND 4) FACILITATE COOPERATIVE RESEARCH INTERACTIONS DOMESTICALLY AND INTERNATIONALLY BETWEEN THE KUMC AND CORPORATIONS, AND WITH OTHER RESEARCH CENTERS THROUGHOUT THE GREATER KANSAS CITY METROPOLITAN AREA.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$179.1M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)